TrialClinical pharmacokinetics2018

Pharmacokinetics of MHAA4549A, an Anti-Influenza A Monoclonal Antibody, in Healthy Subjects Challenged with Influenza A Virus in a Phase IIa Randomized Trial.

Rong Deng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.